サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1159171

トロンボポエチン受容体の世界市場（2022年～2028年）

Thrombopoietin Receptor Market 2022-2028
出版日: | 発行: Orion Market Research | ページ情報: 英文 114 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
トロンボポエチン受容体の世界市場（2022年～2028年）
出版日: 2022年09月16日
発行: Orion Market Research
ページ情報: 英文 114 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のトロンボポエチン受容体の市場規模は、予測期間中に大幅なCAGRで成長すると予想されています。各社が開発した医薬品に対するFDAの承認の増加は、市場の成長を促進しています。

当レポートでは、世界のトロンボポエチン受容体市場について調査分析し、市場概要、競合情勢、市場分析、企業プロファイルなど、体系的な情報を提供しています。

目次

第1章 レポートの概要

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向

第3章 競合情勢

  • Novartis International AG
  • Amgen Inc.
  • GlaxoSmithKline plc
  • AstraZeneca PLC
  • Takeda Pharmaceutical Company Ltd.
  • 主要戦略分析
  • COVID-19が主要企業に与える影響

第4章 市場セグメンテーション

  • 世界のトロンボポエチン受容体市場：タイプ別
    • エルトロンボパグオラミン
    • GSK-2285921
    • ロミプロスチム
    • STST-4
    • その他
  • 世界のトロンボポエチン受容体市場：エンドユーザー別
    • クリニック
    • 病院
    • その他

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • 世界のその他の地域

第6章 企業プロファイル

  • Intas Pharmaceuticals Ltd.
  • Rigel Pharmaceuticals, Inc.
  • Shionogi & Co., Ltd.
  • STATegics Inc.
  • AkaRx Inc
  • 3SBio Inc
図表

LIST OF TABLES

  • 1. GLOBAL THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 2. GLOBAL ELTROMBOPAG OLAMINE THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL GSK-2285921 THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL ROMIPLOSTIM THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 5. GLOBAL STST-4 THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 6. GLOBAL OTHER THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 7. GLOBAL THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028($ MILLION)
  • 8. GLOBAL THROMBOPOIETIN RECEPTOR MARKET IN CLINIC MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 9. GLOBAL THROMBOPOIETIN RECEPTOR MARKET IN HOSPITAL MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 10. GLOBAL THROMBOPOIETIN RECEPTOR MARKET IN OTHER END-USERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028($ MILLION)
  • 11. GLOBAL THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028($ MILLION)
  • 12. NORTH AMERICAN THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 13. NORTH AMERICAN THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 14. NORTH AMERICAN THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 15. EUROPEAN THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 16. EUROPEAN THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028($ MILLION)
  • 17. EUROPEAN THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 18. ASIA-PACIFIC THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 19. ASIA-PACIFIC THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 20. ASIA-PACIFIC THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
  • 21. REST OF THE WORLD THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 22. REST OF THE WORLD THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 23. REST OF THE WORLD THROMBOPOIETIN RECEPTOR MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL THROMBOPOIETIN RECEPTOR MARKET, 2021-2028 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL THROMBOPOIETIN RECEPTOR MARKET BY SEGMENT, 2021-2028 ($ MILLION)
  • 3. RECOVERY OF GLOBAL THROMBOPOIETIN RECEPTOR MARKET, 2021-2028 (%)
  • 4. GLOBAL THROMBOPOIETIN RECEPTOR MARKET SHARE BY TYPE, 2021 VS 2028 (%)
  • 5. GLOBAL ELTROMBOPAG OLAMINE THROMBOPOIETIN RECEPTOR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 6. GLOBAL GSK-2285921 THROMBOPOIETIN RECEPTOR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 7. GLOBAL ROMIPLOSTIM THROMBOPOIETIN RECEPTOR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 8. GLOBAL STST-4 THROMBOPOIETIN RECEPTOR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 9. GLOBAL OTHER THROMBOPOIETIN RECEPTOR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 10. GLOBAL THROMBOPOIETIN RECEPTOR MARKET SHARE BY END-USER, 2021 VS 2028 (%)
  • 11. GLOBAL THROMBOPOIETIN RECEPTOR MARKET IN CLINIC MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 12. GLOBAL THROMBOPOIETIN RECEPTOR MARKET IN HOSPITAL MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 13. GLOBAL THROMBOPOIETIN RECEPTOR MARKET IN OTHER END-USER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 14. GLOBAL THROMBOPOIETIN RECEPTOR MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 15. US THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)
  • 16. CANADA THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)
  • 17. UK THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)
  • 18. FRANCE THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)
  • 19. GERMANY THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)
  • 20. ITALY THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. SPAIN THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. REST OF EUROPE THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. INDIA THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)
  • 24. CHINA THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)
  • 25. JAPAN THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)
  • 26. SOUTH KOREA THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)
  • 27. REST OF ASIA-PACIFIC THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)
  • 28. REST OF THE WORLD THROMBOPOIETIN RECEPTOR MARKET SIZE, 2021-2028 ($ MILLION)
目次
Product Code: OMR2025870

Global Thrombopoietin Receptor Market Size, Share and Trends Analysis Report by Type (Eltrombopag Olamine, GSK-2285921, Romiplostim, STST-4, Others), by Application (Clinic, Hospital, Others) Forecast Period (2022-2028)

The global thrombopoietin receptor market is expected to rise at a substantial CAGR during the forecast period. The factors that are significantly contributing to the growth of the market include FDA approvals to the drugs developed by the companies and new launches by the market players operating in the thrombopoietin receptor market. For instance, in June 2019, Dova Pharmaceuticals, Inc. announced the approval of a supplemental New Drug Application (sNDA) that expands the use of DOPTELET (avatrombopag) by the US Food and Drug Administration (FDA). Moreover, in Oct 2019, Amgen announced that the U.S. Food and Drug Administration (FDA) approved Amgen's Supplemental Biologics License Application (sBLA) for Nplate® (romiplostim). The drug is used to treat adults with immune thrombocytopenia (ITP).

The global thrombopoietin receptor market is segmented based on type and application. Based on type, the market is segmented into Eltrombopag Olamine, GSK-2285921, Romiplostim, STST-4, Others. Based on application the market is segmented into Clinic, Hospital, Others. For instance, Promacta is a prescription pharmaceutical used to treat low blood platelet counts caused by persistent immune thrombocytopenia (ITP) in adults and children aged 1 year and older when previous ITP medications or spleen removal surgery have failed.

The global thrombopoietin receptor market is further segmented based on geography Including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East and Africa, and Latin America).

The major companies serving the Global Thrombopoietin Receptor market include Novartis International AG, Amgen Inc., GlaxoSmithKline plc, 3SBio, Inc., AkaRx, Inc., and others. The market players are contributing significantly to the growth of the market by the adoption of various strategies, including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market.

Research Methodology

The market study of the Global Thrombopoietin Receptor market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • Global Thrombopoietin Receptor Market Research and Analysis by Type
  • Global Thrombopoietin Receptor Market Research and Analysis by Application

The Report Covers:

  • Comprehensive Research Methodology of the Global Thrombopoietin Receptor Market.
  • This report additionally includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Global Thrombopoietin Receptor Market.
  • Insights about market determinants that are stimulating the Global Thrombopoietin Receptor Market.
  • The regional distribution of forecasted revenues with detailed and extensive market segments.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on The Global Thrombopoietin Receptor Market
  • Recovery Scenario of Global Thrombopoietin Receptor Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Novartis International AG
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Amgen Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. GlaxoSmithKline plc
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. Swot Analysis
    • 3.3.4. Recent Developments
  • 3.4. AstraZeneca PLC
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments

3.5. Takeda Pharmaceutical Company Ltd.

    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis
  • 3.7. Impact of Covid-19 on Key Players

4. Market Segmentation

  • 4.1. Global Thrombopoietin Receptor Market by Type
    • 4.1.1. Eltrombopag Olamine
    • 4.1.2. GSK-2285921
    • 4.1.3. Romiplostim
    • 4.1.4. STST-4
    • 4.1.5. Others
  • 4.2. Global Thrombopoietin Receptor Market by END-USER
    • 4.2.1. Clinic
    • 4.2.2. Hospital
    • 4.2.5. Others

5. Regional Analysis

  • 5.1. North America

5.1.1 United States

5.1.2 Canada

5.2. Europe

    • 5.2.1.UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 5.5. Intas Pharmaceuticals Ltd.
  • 5.6. Rigel Pharmaceuticals, Inc.
  • 5.7. Shionogi & Co., Ltd.
  • 5.8. STATegics Inc.
  • 5.9. AkaRx Inc
  • 5.10. 3SBio Inc